文献速递神经MR

代谢-血流灌注栖息地成像预测高级别胶质瘤个体无进展生存期

Metabolic habitat imaging with hemodynamic heterogeneity predicts individual progression-free survival in high-grade glioma.
PubMed 文献 · Clin Radiol · 2024-03-15

前瞻性收集69例高级别胶质瘤患者同步放化疗后术前多参数MRI数据,通过血管栖息地分割结合代谢信息构建线性回归模型,发现高血管生成强化肿瘤栖息地灌注指标与Cho/Cr及Cho/NAA比值强相关,IDH野生型较突变型Cho/Cr及Cho/NAA比值显著降低,基于代谢比值的列线图预测中位无进展生存期的C指数分别为0.769和0.747。

要点

  • 高血管生成强化肿瘤栖息地中rCBV与Cho/Cr比值强相关(r=0.71),与Cho/NAA比值相关(r=0.66)。
  • IDH野生型较高血管生成强化肿瘤栖息地Cho/Cr比值显著低于突变型(2.66±0.36 vs 2.44±0.33,p=0.02)。
  • 基于Cho/NAA和Cho/Cr的列线图预测中位无进展生存期C指数分别为0.769和0.747。

核心结论

  • 空间代谢联合血流动力学异质性与高级别胶质瘤患者同步放化疗后个体无进展生存期相关。

研究设计与样本

  • 前瞻性可行性研究,纳入69例经组织学确诊的高级别胶质瘤患者,收集2016年1月至2020年3月术前多参数MRI数据,患者均接受同步放化疗。

关键影像表现/征象

  • 通过多参数MRI自动分割出四个血管栖息地。
  • 由两名神经放射科医生获取强化区或水肿区肿瘤区域的代谢信息。
  • 高血管生成强化肿瘤栖息地中灌注指标与Cho/Cr比值强相关(rCBV,r=0.71),与Cho/NAA比值相关(rCBV,r=0.66)。
  • IDH野生型较高血管生成强化肿瘤栖息地Cho/Cr比值显著低于IDH突变型(2.66±0.36 vs 2.44±0.33,p=0.02)。
  • IDH野生型较高血管生成强化肿瘤栖息地Cho/NAA比值显著低于IDH突变型(4.99±0.66 vs 4.59±0.61,p=0.022)。

诊断标准与关键数值

  • 使用相对栖息地体积进行权重估计,通过加权最小二乘法计算线性回归模型系数,用于血管栖息地代谢物半定量(Cho/NAA比值和Cho/Cr比值)。
  • 采用多因素Cox比例风险回归分析获得比值比(OR),并基于Cox回归系数衍生的加权估计量构建列线图。
  • 通过1000次自举验证,Cho/NAA列线图预测中位无进展生存期的C指数为0.769,Cho/Cr列线图为0.747。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: We design a feasibility study to obtain a set of metabolic-hemodynamic habitats for tackling tumor spatial metabolic patterns with hemodynamic information.

MATERIALS AND METHODS: Preoperative data from 69 high-grade gliomas (HGG) patients with subsequent histologic confirmation of HGG were prospectively collected (January 2016 to March 2020) after concurrent chemoradiotherapy (CCRT). Four vascular habitats were automatically segmented by multiparametric magnetic resonance imaging (MRI). The metabolic information, either at enhancing or edema tumor regions, was obtained by two neuroradiologists. The relative habitat volumes were used for weight estimation procedures for computing the coefficients of a linear regression model using weighted least squares (WLS) for metabolite semiquantifications (i.e. the Cho/NAA ratio and the Cho/Cr ratio) at vascular habitats. Multivariate Cox proportional hazard regression analyses are used to obtain the odds ratio (OR) and develop a nomogram using weighted estimators corresponding to each covariate derived from Cox regression coefficients.

RESULTS: There was a strongly correlation between perfusion indexes and the Cho/Cr ratio (rCBV, r=0.71) or Cho/NAA ratio (rCBV, r=0.66) at high-angiogenic enhancing tumor habitats (HAT) habitat. Compared isocitrate dehydrogenase (IDH) mutation to their wild type, the IDH wild type had significantly decreased Cho/Cr ratio (IDH mutation: Cho/Cr ratio = 2.44 ± 0.33, IDH wildtype: Cho/Cr ratio = 2.66 ± 0.36, p=0.02) and Cho/NAA ratio (IDH mutation: Cho/Cr ratio = 4.59 ± 0.61, IDH wildtype: Cho/Cr ratio = 4.99 ± 0.66, p=0.022) at the HAT. The C-index for the median progression-free survival (PFS) prediction was 0.769 for the Cho/NAA nomogram and 0.747 for the Cho/Cr nomogram through 1000 bootstrapping validation.

CONCLUSIONS: Our findings suggest that spatial metabolism combined with hemodynamic heterogeneity is associated with individual PFS to HGG patients post-CCRT.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Qiao J, Kang H, Ran Q, et al. Metabolic habitat imaging with hemodynamic heterogeneity predicts individual progression-free survival in high-grade glioma. Clin Radiol. 2024. PMID: 38582632. doi:10.1016/j.crad.2024.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。